Power Law company profile

Beam Therapeutics

Biotech & Life Sciences · Cambridge, United States · Founded 2017 · IPO 2020 Unicorn

developing precision genetic medicines for serious diseases

Valuation

$2.02B

Market cap · May/2026

Revenue

$56M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

10 investors on Beam Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 10 investors entered at this stage

Cormorant Asset Management

Omega Funds

Redmile Group

Dreamers

DHVC

F-Prime

Altitude Life Science Ventures

Eight Roads Ventures

Harvard University

ARCH Venture Partners

Global footprint

Where Beam Therapeutics has talent and traffic

AI talent share

0.9% of workforce is AI talent
(5 of 573 staff)

Core AI10.17%

Other AI40.7%

Non-AI workforce56899.13%

Workforce by country

3 countries with
team presence

🇺🇸 United States99.5%

🇵🇹 Portugal0.2%

🏳️ Liechtenstein0.2%

3 countries shown

Web traffic by country

43K monthly visits
across markets

🇺🇸 United States70.7%

🇨🇦 Canada7%

🇬🇧 United Kingdom6.5%

🇮🇳 India4.7%

🏳️ Korea4%

Top 5 markets shown

Patent intelligence

$18M patent portfolio · 87 active families

Estimated portfolio value

$18M

0.88% of market cap · 13.4× smaller than top peer Juno Therapeutics ($239M)

87 active patent families

Where Beam Therapeutics innovates Cell biologyMolecular biologyPolynucleotideBase JCell

Where Beam Therapeutics concentrates vs peers

Each axis is a top-10 topic across Beam Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Beam Therapeutics

An AI-synthesized read of the highest-engagement posts about Beam Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Beam Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles